Giles Kerr

Appointed to the Board in October 2015, becoming Chairman in May 2020.

Gile’s former roles include chief financial officer at the University of Oxford, Group finance director at Amersham plc, Arther Anderson & Co, and non-executive director roles at BTG plc, Victrex plc, Elan Corporation Inc and Adaptimmune Therapeutics plc. Giles is a non-executive director of Senior plc, Abcam plc, and Arix Bioscience plc.